Table 6.
1. Peripheral blood white blood cell count ≥ 13 × 109/La | |
Segmented neutrophils plus banded neutrophils constitute ≥ 80% of the white blood cells | |
No significant dysgranulopoiesis | |
Circulating blasts only rarely observedb | |
Monocyte count < 10% of all leukocytes | |
2. Hypercellular bone marrow with neutrophil granulocytes increased in percentage and absolute number, showing normal maturation | |
3. CSF3R T618I or another activating CSF3R mutation or persistent neutrophilia (≥ 3 months), splenomegaly, and no identifiable cause of reactive neutrophilia including absence of a plasma cell neoplasm or, if a plasma cell neoplasm is present, demonstration of clonality of myeloid cells by cytogenetic or molecular studies | |
4. Not meeting diagnostic criteria for BCR::ABL1-positive chronic myeloid leukemia, polycythemia vera, essential thrombocythemia, primary myelofibrosis, or of a myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions |
The diagnosis of CNL requires all 4 criteria
a≥ 25 × 109/L in cases lacking CSF3R T618I or another activating CSF3R mutation
b10–19% blasts in peripheral blood or bone marrow represent CNL in accelerated phase (AP); > 20% blasts represent blast phase (BP)